Blue Cross Blue Shield · 17ohp Compounded · US health-plan appeal rights

17ohp Compounded denied for failing step therapy by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield 17ohp Compounded denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for 17ohp compounded are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: BCBS Compounded 17-OHP Coverage Post-Makena Withdrawal

The Blue Cross Blue Shield angle on 17ohp Compounded

## Why BCBS Denied This Under Step Therapy

Blue Cross Blue Shield's step-therapy (also called "fail-first") policy requires that patients try one or more lower-cost or preferred formulary drugs before the insurer will cover a non-preferred or more expensive agent. For compounded 17-hydroxyprogesterone caproate, BCBS may require documented trials with commercially available progesterone alternatives before approving the compounded formulation.

Step-therapy denials are among the most commonly appealed — and among the most commonly reversed — especially when: (a) you have already tried a required step-therapy agent and it failed, was not tolerated, or was contraindicated; or (b) your prescriber can document why starting at the required step would be clinically inappropriate for your specific situation. Many states also have step-therapy reform laws that give patients additional rights, particularly around exceptions.

## Federal Appeal Rights

ACA §2719 external review: If internal appeal fails, request independent external review. IROs apply clinical standards and frequently overturn step-therapy denials when prior-treatment history is well-documented. File within the window in your denial notice — typically around four months from the denial date.
State step-therapy exception laws: Many states have enacted laws requiring insurers to grant step-therapy exceptions when an earlier-step drug is contraindicated, has failed, or would cause harm. Check whether your state's law applies to your plan type.
ERISA §503: For self-funded ERISA plans, state step-therapy laws may not apply, but full and fair review rights remain.
Expedited review: Available when delay poses a clinical risk.

## Concrete Appeal Steps

1. Identify the specific step-therapy requirement from the denial letter — which drug(s) must be tried first. 2. Obtain BCBS's step-therapy exception policy and identify the grounds for an exception (prior failure, contraindication, clinical urgency, etc.). 3. Compile your prior-treatment history (see below) demonstrating compliance with or valid exception from the required steps. 4. Have your prescriber write a letter addressing the step-therapy criteria directly — either documenting prior trial and failure, or explaining the clinical reason why the required step is not appropriate. 5. Submit an internal appeal within your plan's deadline, typically 180 days from denial. 6. If denied, file for external review and note any applicable state step-therapy exception law.

## Documentation to Gather

Diagnosis confirmation: Obstetric records establishing the indication.
Prior-treatment history: This is the core of a step-therapy appeal. For each required step-therapy agent: the drug name, start date, stop date, reason for discontinuation (lack of efficacy, adverse effect, contraindication), and the chart note documenting that reason.
Clinical-severity documentation: Records showing the urgency or severity of the clinical situation, particularly if delay in therapy poses a risk.
Prescriber medical-necessity letter: Should address each step-therapy requirement specifically — confirming prior trial and failure, or explaining with clinical specificity why the required step is inappropriate for this patient. Reference the applicable professional obstetric guideline organization's recommendations where relevant.

## Criteria-Mapping Structure

| BCBS Step-Therapy Requirement | Documentation Demonstrating Compliance or Exception | |---|---| | List of required step-therapy drugs from the BCBS policy | Prior-treatment records for each: dates, outcomes, chart notes | | Exception criteria (contraindication, prior failure, clinical urgency) | Prescriber letter section addressing the applicable exception basis | | Any time-on-therapy or documentation requirements | Chart entries with dates confirming the treatment history |

Step-therapy policies vary by BCBS affiliate, plan type, and benefit year. Always review the current policy applicable to your plan before filing.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield 17ohp Compounded

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.